In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 1146 for your search:
Drug:  filgrastim
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Unknown
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631

2.

Phase: Phase IV
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ACCOG-SCTN-BR0101, SCTN-BR0101, EU-20143, NCT00030758

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004

4.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017

5.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 50 and under
Sponsor: Other
Protocol IDs: CDR0000066400, MSGCC-9739, NCI-V98-1433, NCT00003398

6.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 78
Sponsor: Other
Protocol IDs: MOZ11809, MSC12830, NCT01164475

7.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CABAZ_L_06003, U1111-1123-9025, NCT01649635

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDL-3-251, MSKCC-93131, NCI-V94-0469

9.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8

10.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 16 to 50
Sponsor: Other
Protocol IDs: EORTC-30983, NCT00003643

11.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 50
Sponsor: Other
Protocol IDs: CHIMERIC-HM01, WSU-10-02-99-M01-FB, NCT00004255

12.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 0 to 18
Sponsor: NCI
Protocol IDs: CCG-3891

13.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: E-1193, NCCTG-923252, SWOG-9332, E-10292, E1193

14.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AHOD0121, CDR0000330135, COG-AHOD0121, NCT00070187

15.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 04/Q1907/94, NCT00234143

16.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 to 69
Sponsor: Other
Protocol IDs: JCOG0203, C000000033, NCT00147121

17.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 55 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000066016, P30CA016059, MCV-CCHR-9504-2X, DUMC-75951, NCI-G98-1388, NCT00003187

18.

Phase: Phase III, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: FCCC-94001, NCI-V94-0479

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9313, CLB-9394, E-S9313, NCCTG-933051, INT-0137

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no greater than 60
Sponsor: NCI
Protocol IDs: NU-93B1, NCI-T93-0058D, T93-0058

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-26

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9342, CALGB-9342

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no greater than 65
Sponsor: NCI
Protocol IDs: FHCRC-772.01, NCI-H94-0370

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LU19, EU-93027
1     
New Search